about
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of ...
Read More
21.71
-0.46
(-2.07%)
10.5M
XNYS Volume
XNYS 30 Jul, 2025 3:55 PM (EDT)
Board Meeting
The next board meeting for Kenvue Inc is on 07 Aug 2025 for the purpose of Kenvue Inc Second Quarter Earnings Conference Call for 2025
See details
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Kenvue Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..